Fimecs

FIMECS focuses on drug discovery based on targeted protein degradation, utilizing its proprietary RaPPIDS™ platform technology to develop drugs for currently 'undruggable' targets

fimecs.com

Biotech & Life Sciences

Sector

Seed

Stage

B2B collaborations with pharmaceutical companies

Model

01Company Overview

FIMECS focuses on drug discovery based on targeted protein degradation, utilizing its proprietary RaPPIDS™ platform technology to develop drugs for currently 'undruggable' targets.

02Backed By1 investor

UIUTokyo Innovation Platform→

03Similar Companies